Crossmark

Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study)

Crossref DOI link: https://doi.org/10.1186/s12904-023-01143-2

Published Online: 2023-03-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kistemaker, K.R.J.

de Graeff, A.

Crul, M.

de Klerk, G.

van de Ven, P.M.

van der Meulen, M.P.

van Zuylen, L.

Steegers, M.A.H.
Funding

Funding for this research was provided by:

ZonMw (08440012010002, 08440012010002, 08440012010002, 08440012010002, 08440012010002, 08440012010002, 08440012010002, 08440012010002)
License Information

Text and Data Mining valid from 2023-03-14

Version of Record valid from 2023-03-14
More Information

Article History

Received: 24 February 2023

Accepted: 8 March 2023

First Online: 14 March 2023

Declarations

:

: This study is approved by the Medical Ethics committee of Amsterdam UMC, the Netherlands. The informed consent procedure meets all the requirements of the ICH-GCP guidelines.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below